R&D expenditure of GW Pharmaceuticals 2017-2020
In 2020, GW Pharmaceuticals spent around 205 million U.S. dollars on research and development, which is a significant increase from around 112 million U.S. dollars spent in 2017. This statistic illustrates the research and development expenditure of GW Pharmaceuticals worldwide from 2017 to 2020. In May 2021, the company was acquired by Ireland-based biopharma company Jazz Pharmaceuticals.